tiprankstipranks
Amicus Therapeutics (FOLD)
NASDAQ:FOLD
US Market

Amicus (FOLD) Financial Statements

Compare
989 Followers

Amicus Financial Overview

Amicus's market cap is currently $2.94B. The company's EPS TTM is $-0.184; its P/E ratio is ―; Amicus is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $-0.05. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 399.36M$ 329.23M$ 305.51M$ 260.89M$ 182.24M
Gross Profit$ 362.03M$ 290.63M$ 271.05M$ 229.84M$ 160.27M
Operating Income$ -73.49M$ -204.43M$ -199.92M$ -243.85M$ -300.74M
EBITDA$ -92.08M$ -199.58M$ -202.87M$ -242.98M$ -332.26M
Net Income$ -151.58M$ -236.57M$ -250.46M$ -276.85M$ -356.39M
Balance Sheet
Cash & Short-Term Investments$ 286.20M$ 293.60M$ 482.50M$ 483.27M$ 452.74M
Total Assets$ 777.88M$ 724.17M$ 905.14M$ 886.52M$ 850.21M
Total Debt$ 445.06M$ 452.12M$ 440.13M$ 441.73M$ 210.22M
Net Debt$ 198.06M$ 303.31M$ 194.93M$ 278.49M$ 67.39M
Total Liabilities$ 617.71M$ 601.12M$ 597.77M$ 600.14M$ 373.78M
Stockholders' Equity$ 160.17M$ 123.05M$ 307.37M$ 286.38M$ 476.43M
Cash Flow
Free Cash Flow$ -76.53M$ -170.34M$ -206.38M$ -236.52M$ -270.43M
Operating Cash Flow$ -69.09M$ -166.57M$ -202.49M$ -233.29M$ -250.42M
Investing Cash Flow$ 98.06M$ 92.32M$ 78.76M$ -13.58M$ 95.15M
Financing Cash Flow$ 61.68M$ -7.46M$ 212.07M$ 262.86M$ 217.50M
Currency in USD

Amicus Earnings and Revenue History

Amicus Debt to Assets

Amicus Cash Flow

Amicus Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis